SCHEMBL23919175

SCHEMBL23919175

CC(C)C(C)C(=O)Nc1ccc(-c2ccc(-c3cnc4cc(Cl)ccc4n3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP7 Q9BQF6 3/20 0.47
CASP3 P42574 3/20 0.47
JAK3 P52333 2/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.42
CYP2C9 P11712 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
FGFR3 P22607 1/20 0.40
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40
HPGD P15428 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30723199 0.91 SENP7 (0.57) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL21793711 0.91 SENP7 (0.57) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL30723187 0.90 SENP7 (0.58) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL21793874 0.90 SENP7 (0.58) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL21793861 0.83 KMT2A (0.56) SENP7CASP3NPC1RAB9ASMN1; SMN2
SCHEMBL30723192 0.83 KMT2A (0.56) SENP7CASP3NPC1RAB9ASMN1; SMN2
SCHEMBL21793707 0.83 SENP7 (0.62) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL21793867 0.82 SENP7 (0.64) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL23908580 0.80 SENP7 (0.62) SENP7CASP3JAK3NPC1RAB9A
SCHEMBL21793708 0.80 NPC1 (0.48) NPC1RAB9ASMN1; SMN2MEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317095-A1 COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS ALBERT EINSTEIN COLLEGE OF MEDICINE 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317095-A1 COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS SQSTM1, HSPA5, ATG7 SENP7 3099/4885CASP3 2834/4885JAK3 4416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.